Obstructive Sleep Apnea and Diabetes: A State of the Art Review.

OSA is a chronic treatable sleep disorder and a frequent comorbidity in patients with type 2 diabetes. Cardinal features of OSA, including intermittent hypoxemia and sleep fragmentation, have been linked to abnormal glucose metabolism in laboratory-based experiments. OSA has also been linked to the development of incident type 2 diabetes. The relationship between OSA and type 2 diabetes may be bidirectional in nature given that diabetic neuropathy can affect central control of respiration and upper airway neural reflexes, promoting sleep-disordered breathing. Despite the strong association between OSA and type 2 diabetes, the effect of treatment with CPAP on markers of glucose metabolism has been conflicting. Variability with CPAP adherence may be one of the key factors behind these conflicting results. Finally, accumulating data suggest an association between OSA and type 1 diabetes as well as gestational diabetes. This review explores the role of OSA in the pathogenesis of type 2 diabetes, glucose metabolism dysregulation, and the impact of OSA treatment on glucose metabolism. The association between OSA and diabetic complications as well as gestational diabetes is also reviewed.

[1]  B. Mokhlesi,et al.  The Effect of OSA Therapy on Glucose Metabolism: It's All about CPAP Adherence! , 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[2]  P. Strollo,et al.  Effect of continuous positive airway pressure (CPAP) on glycemic control and variability in type 2 diabetes , 2017, Sleep and Breathing.

[3]  J. Pankow,et al.  Obstructive sleep apnea and incident type 2 diabetes. , 2016, Sleep medicine.

[4]  D. Hillman,et al.  Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  J. Born,et al.  Hypoxia causes glucose intolerance in humans. , 2004, American journal of respiratory and critical care medicine.

[6]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[7]  J. Holst,et al.  Neural regulation of glucagon-like peptide-1 secretion in pigs. , 2004, American journal of physiology. Endocrinology and metabolism.

[8]  J. Stradling,et al.  CPAP and measures of cardiovascular risk in males with OSAS , 2008, European Respiratory Journal.

[9]  D. Bouhassira,et al.  Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis , 2016, Sleep medicine.

[10]  T. Gislason,et al.  The role of habitual snoring and obesity in the development of diabetes: a 10‐year follow‐up study in a male population , 2000, Journal of internal medicine.

[11]  F. Weaver,et al.  Effects of positive airway pressure treatment on clinical measures of hypertension and type 2 diabetes. , 2012, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[12]  P. Cistulli,et al.  Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. , 1994, The Journal of clinical endocrinology and metabolism.

[13]  T. Young,et al.  Increased prevalence of sleep-disordered breathing in adults. , 2013, American journal of epidemiology.

[14]  J. Fleetham,et al.  The Impact of CPAP on Cardiovascular Biomarkers in Minimally Symptomatic Patients with Obstructive Sleep Apnea: A Pilot Feasibility Randomized Crossover Trial , 2008, Lung.

[15]  Anne W. Taylor,et al.  Nocturnal Hypoxemia and Severe Obstructive Sleep Apnea are Associated with Incident Type 2 Diabetes in a Population Cohort of Men. , 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[16]  J. Romijn,et al.  A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. , 2010, The Journal of clinical endocrinology and metabolism.

[17]  J. Polák,et al.  Screening for obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus: a prospective study on sensitivity of Berlin and STOP-Bang questionnaires. , 2016, Sleep medicine.

[18]  S. Shott,et al.  Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. , 2005, Archives of internal medicine.

[19]  E. van Cauter,et al.  Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363 , 2014, Diabetes Care.

[20]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for type 2 diabetes. , 2009, The American journal of medicine.

[21]  J. Ficker,et al.  Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. , 2004, American journal of respiratory and critical care medicine.

[22]  C. O'Donnell,et al.  Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic β‐cell replication in mice , 2008, The Journal of physiology.

[23]  F. Goupil,et al.  Association between obstructive sleep apnea severity and glucose control in patients with untreated versus treated diabetes , 2015, Journal of sleep research.

[24]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[25]  S. Redline,et al.  Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas , 2016, Cardiovascular Diabetology.

[26]  J. Shaw,et al.  The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes. , 2016, American journal of respiratory and critical care medicine.

[27]  Duanping Liao,et al.  Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females , 2013, European Respiratory Journal.

[28]  T. Wadden,et al.  CPAP, weight loss, or both for obstructive sleep apnea. , 2014, The New England journal of medicine.

[29]  J. Stradling,et al.  Clinical Outcomes and Cost-effectiveness of Continuous Positive Airway Pressure to Manage Obstructive Sleep Apnea in Patients With Type 2 Diabetes in the U.K. , 2014, Diabetes Care.

[30]  Anne Newman,et al.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. , 2003, Diabetes care.

[31]  G. Slama,et al.  Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. , 2009, Diabetes & metabolism.

[32]  J. Heffner,et al.  Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. , 2012, Chest.

[33]  N. Prabhakar,et al.  Impairment of pancreatic β‐cell function by chronic intermittent hypoxia , 2013, Experimental physiology.

[34]  Deepak L. Bhatt,et al.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5‐Year Outcomes , 2017, The New England journal of medicine.

[35]  E. van Cauter,et al.  Impaired Insulin Signaling in Human Adipocytes After Experimental Sleep Restriction , 2012, Annals of Internal Medicine.

[36]  E. van Cauter,et al.  Effect of one week of CPAP treatment of obstructive sleep apnoea on 24‐hour profiles of glucose, insulin and counter‐regulatory hormones in type 2 diabetes , 2017, Diabetes, obesity & metabolism.

[37]  V. Somers,et al.  Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. , 1999, Circulation.

[38]  J. Pépin,et al.  Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. , 2015, Sleep medicine reviews.

[39]  J. Holst,et al.  Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. , 1997, The Journal of clinical endocrinology and metabolism.

[40]  T. Yao,et al.  A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea , 2009, European Respiratory Journal.

[41]  Rachel Leproult,et al.  Slow-wave sleep and the risk of type 2 diabetes in humans , 2008, Proceedings of the National Academy of Sciences.

[42]  Naresh M Punjabi,et al.  Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. , 2008, Diabetes research and clinical practice.

[43]  K. Jones,et al.  Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. , 2012, JAMA.

[44]  H. Schiöth,et al.  A single night of partial sleep loss impairs fasting insulin sensitivity but does not affect cephalic phase insulin release in young men , 2016, Journal of sleep research.

[45]  T. Wadden,et al.  A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. , 2009, Archives of internal medicine.

[46]  E. van Cauter,et al.  Effect of One Week of 8-Hour Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes: A Proof-of-Concept Study. , 2016, American journal of respiratory and critical care medicine.

[47]  M. Preisig,et al.  Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. , 2015, The Lancet. Respiratory medicine.

[48]  J. Pépin,et al.  High prevalence of obstructive sleep apnoea syndrome in a Type 1 diabetic adult population: a pilot study , 2010, Diabetic Medicine.

[49]  N. Punjabi,et al.  Alterations in Glucose Disposal in Sleep-disordered Breathing. , 2009, American journal of respiratory and critical care medicine.

[50]  P J Mills,et al.  Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. , 2001, Chest.

[51]  J. Christman,et al.  Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. , 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[52]  S. Redline,et al.  A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. , 2012, Sleep.

[53]  L. Czupryniak,et al.  Sleep disordered breathing in REM sleep reverses the downward trend in glucose concentration. , 2011, Sleep medicine.

[54]  F. Abboud,et al.  Sympathetic-nerve activity during sleep in normal subjects. , 1993, The New England journal of medicine.

[55]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[56]  Shuiqing Lai,et al.  Continuous positive airway pressure and diabetes risk in sleep apnea patients: A systemic review and meta-analysis. , 2017, European journal of internal medicine.

[57]  D. Greenburg,et al.  Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. , 2009, The American journal of medicine.

[58]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[59]  K. Oltmanns,et al.  Selective slow wave sleep but not rapid eye movement sleep suppression impairs morning glucose tolerance in healthy men , 2013, Psychoneuroendocrinology.

[60]  Z. Tomori,et al.  Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. , 2008, Diabetes research and clinical practice.

[61]  C. Hoyos,et al.  Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study , 2012, Thorax.

[62]  I. Idris,et al.  Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. , 2011, Diabetes technology & therapeutics.

[63]  S. Redline,et al.  Association between Glucose Metabolism and Sleep-disordered Breathing during REM Sleep. , 2015, American journal of respiratory and critical care medicine.

[64]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[65]  K. Wroblewski,et al.  Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial. , 2015, American journal of respiratory and critical care medicine.

[66]  Naresh M Punjabi,et al.  Effects of sleep fragmentation on glucose metabolism in normal subjects. , 2010, Chest.

[67]  S. Esnaola,et al.  Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. , 2001, American journal of respiratory and critical care medicine.

[68]  J. Lalau,et al.  Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome. , 2011, Diabetes research and clinical practice.

[69]  J. Stradling,et al.  Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes , 2007, Thorax.

[70]  I. Janszky,et al.  Sleep Disturbances and Glucose Metabolism in Older Adults: The Cardiovascular Health Study , 2015, Diabetes Care.

[71]  D. Kripke,et al.  CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[72]  Harry Whitmore,et al.  Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. , 2010, American journal of respiratory and critical care medicine.

[73]  E. van Cauter,et al.  Annals of the New York Academy of Sciences Interactions between Sleep, Circadian Function, and Glucose Metabolism: Implications for Risk and Severity of Diabetes , 2022 .

[74]  David Kelley,et al.  Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes , 2009, Diabetes Care.

[75]  N. Marshall,et al.  Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? , 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[76]  E. van Cauter,et al.  Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. , 2016, Sleep medicine reviews.

[77]  Á. Hernanz,et al.  Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial. , 2016, American journal of respiratory and critical care medicine.

[78]  J. Pépin,et al.  Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. , 2014, Chest.

[79]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[80]  N. Crum‐Cianflone,et al.  Sleep Characteristics, Mental Health, and Diabetes Risk , 2013, Diabetes Care.

[81]  J. Hedner,et al.  Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. , 2010, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[82]  L. Aronne,et al.  Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial , 2016, International Journal of Obesity.

[83]  S. Redolfi,et al.  Autonomic Neuropathy Increases the Risk of Obstructive Sleep Apnea in Obese Diabetics , 2007, Respiration.

[84]  K. Lam,et al.  CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure , 2017, Sleep and Breathing.

[85]  R. Simó,et al.  Effect of glycemic control on nocturnal arterial oxygen saturation: A case‐control study in type 2 diabetic patients 血糖控制对夜间动脉血氧饱和度的影响：一项2型糖尿病患者的病例对照研究 , 2015, Journal of diabetes.

[86]  C. Hoyos,et al.  Meta-analyses of the Association of Sleep Apnea with Insulin Resistance, and the Effects of CPAP on HOMA-IR, Adiponectin, and Visceral Adipose Fat. , 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[87]  R. Simó,et al.  Characterization of Sleep Breathing Pattern in Patients with Type 2 Diabetes: Sweet Sleep Study , 2015, PloS one.

[88]  D. Poyares,et al.  Cardiovascular Autonomic Neuropathy Contributes to Sleep Apnea in Young and Lean Type 1 Diabetes Mellitus Patients , 2014, Front. Endocrinol..

[89]  J. Manson,et al.  Snoring as a risk factor for type II diabetes mellitus: a prospective study. , 2002, American journal of epidemiology.

[90]  E. Bixler,et al.  Prevalence of sleep-disordered breathing in women: effects of gender. , 2001, American journal of respiratory and critical care medicine.

[91]  N. Punjabi,et al.  Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. , 2013, Sleep.

[92]  D. Einhorn,et al.  Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[93]  F. Abboud,et al.  Sympathetic neural mechanisms in obstructive sleep apnea. , 1995, The Journal of clinical investigation.

[94]  K. Nonogaki,et al.  New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.

[95]  E. Bixler,et al.  Effects of age on sleep apnea in men: I. Prevalence and severity. , 1998, American journal of respiratory and critical care medicine.

[96]  P. Calverley,et al.  Cardiovascular and metabolic effects of CPAP in obese males with OSA , 2007, European Respiratory Journal.

[97]  Naresh M Punjabi,et al.  Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. , 2009, Journal of applied physiology.

[98]  D. Gozal,et al.  Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. , 2009, Free radical biology & medicine.

[99]  Wei Wang,et al.  Sleep Restriction for 1 Week Reduces Insulin Sensitivity in Healthy Men , 2010, Diabetes.

[100]  M. Trenell,et al.  Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea , 2012, European Respiratory Journal.

[101]  P. Bottini,et al.  Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy , 2003, European Respiratory Journal.

[102]  C Guilleminault,et al.  Abnormal breathing patterns during sleep in diabetes , 1985, Annals of neurology.

[103]  A. Tahrani,et al.  Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. , 2012, American journal of respiratory and critical care medicine.

[104]  Qifu Li,et al.  The prevalence and characteristics of obstructive sleep apnea in hospitalized patients with type 2 diabetes in China , 2016, Journal of sleep research.

[105]  J. Holst,et al.  The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. , 2001, Diabetes.

[106]  A. Schatzberg,et al.  On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. , 2005, The Journal of clinical endocrinology and metabolism.

[107]  L. Tarnow,et al.  Obstructive sleep apnoea is frequent in patients with type 1 diabetes. , 2017, Journal of diabetes and its complications.

[108]  B. Trimarco,et al.  Acute noradrenergic activation induces insulin resistance in human skeletal muscle. , 1994, The American journal of physiology.

[109]  Oliver Senn,et al.  Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. , 2011, American journal of respiratory and critical care medicine.

[110]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[111]  K. Lam,et al.  Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus. , 2010, Chest.

[112]  S. Saetung,et al.  Shorter sleep duration is associated with poorer glycemic control in type 2 diabetes patients with untreated sleep-disordered breathing , 2016, Sleep and Breathing.

[113]  J. Montserrat,et al.  A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea. , 2016, Sleep.

[114]  David M Maahs,et al.  Epidemiology of type 1 diabetes. , 2010, Endocrinology and metabolism clinics of North America.

[115]  A J Scheen,et al.  Roles of circadian rhythmicity and sleep in human glucose regulation. , 1997, Endocrine reviews.

[116]  M. McConnell,et al.  Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[117]  J. Ficker,et al.  The Effect of Continuous Positive Airway Pressure Treatment on Insulin Sensitivity in Patients with Obstructive Sleep Apnoea Syndrome and Type 2 Diabetes , 2004, Respiration.

[118]  Terry Young,et al.  Association of sleep apnea and type II diabetes: a population-based study. , 2005, American journal of respiratory and critical care medicine.

[119]  M. Sanders,et al.  Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. , 2003, Sleep medicine.

[120]  R. N. Hardy,et al.  The role of the autonomic nervous system in the control of glucagon, insulin and pancreatic polypeptide release from the pancreas. , 1978, The Journal of physiology.

[121]  Tetyana Kendzerska,et al.  Obstructive sleep apnea and incident diabetes. A historical cohort study. , 2014, American journal of respiratory and critical care medicine.

[122]  P. Penev,et al.  Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. , 2009, The Journal of clinical endocrinology and metabolism.

[123]  K. Yamagishi,et al.  Nocturnal intermittent hypoxia and metabolic syndrome; the effect of being overweight: the CIRCS study. , 2010, Journal of atherosclerosis and thrombosis.

[124]  C. Guilleminault,et al.  The impact of autonomic nervous system dysfunction on breathing during sleep. , 1981, Sleep.

[125]  T. Gislason,et al.  Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. , 2012, Chest.

[126]  C. Cobelli,et al.  Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults , 2017, Physiological reports.